Facebook
Twitter
LinkedIn
Forward2021 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes
The 2021 Precision Oncology Summit: Personalizing treatment to improve patient outcomes is a one-day conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of implications of actionable molecular alterations across common malignancies.
Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2021 ASCO Annual Meeting in June 2021.
This conference will augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including:
- Integrating different platforms available for testing of actionable molecular alterations for identification of targeted therapy options.
- Current and evolving paradigms in precision oncology approach for management of common malignancies.
- Trends, challenges, controversies, and cost-considerations of precision oncology approaches and targeted therapies.
Abstract Presentation Information
Abstract Presentation times: 5:00 PM to 6:00 PM on Friday, October 1, 2021 and Saturday, October 2, 2021.
All abstracts will be presented as oral presentations. Each presenter will have 5-minutes for their presentation and 2-minutes for questions and answers. You will present your abstract as a powerpoint presentation not in a poster format.
Abstract Presentation Schedule has been emailed to all accepted abstract authors. You will present your abstract during the time you selected.
All presenters must be fully vaccinated against COVID-19 to be able to present their abstracts.
You must be registered for the conference to present your abstract. If you are a resident or fellow presenting the abstract, please follow the instructions for fellow/resident registration to receive a registration fee waiver.
Target Audience
- Hematologists/Oncologists
- Oncology Nurse Practitioners
- Oncology Pharmacists
- Oncology Physician Assistants
- Oncology Fellows/Residents
- Oncology Nurses
- Researchers and others involved in the care of cancer patients
COVID-19 Precautions
COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in.
Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.
Learning Objectives
Upon successful completion of this educational activity on precision oncology, participants will be able to:
- Identify frequent molecular abnormalities across several common malignancies and understand appropriate timing of testing to detect these abnormalities.
- Interpret results of next generation sequencing and other biomarkers predictive of response to targeted therapies and recognize the challenges involved.
- Explain the role, including advantages and disadvantages, of different testing methodologies available for selection of targeted therapies.
- Plan optimal molecular-targeted treatment strategies for treatment of cancer.
- Outline emerging research, the mechanism of action, and the role of novel molecular-targeted therapies in clinical investigation for cancer patients.
Conference Chair: Neeraj Agarwal, MD
All times are listed in local Mountain Time
6:30 AM to 7:45 AM Breakfast and Registration
7:45 AM to 8:00 AM Chairperson’s Welcome Note – Neeraj Agarwal, MD
8:00 AM to 9:40 AM Session 1: Methods in Precision Oncology
Session Chair: Manish Kohli, MD
8:00 AM to 8:25 AM Tumor sequencing for detection of molecular abnormalities - Jack West, MD
8:25 AM to 8:50 AM Beyond sequencing – methods in identifying tumor biomarkers for targeted therapies – Vivek Subbiah, MD
8:50 AM to 9:15 AM Germline genetic testing for cancer prevention and treatment – Siddhartha Yadav, MD
9:15 AM to 9:40 AM Clinical utility of circulating tumor DNA in cancer treatment – Manish Kohli, MD
9:40 AM to 10:00 AM BREAK
10:00 AM to 11:00 AM Session 2: Precision oncology in breast cancer
Moderator: Christos Vaklavas, MD
10:00 AM to 10:25 AM Targeted therapies in metastatic breast cancer – Stephanie Graff, MD
10:25 AM to 10:50 AM Biomarker adapted strategies in neoadjuvant and adjuvant treatment of non-metastatic breast cancer – Mark Pegram, MD
10:50 AM to 11:15 AM Case-based discussion – Christos Vaklavas, MD
11:15 AM to 12:15 AM Session 3: Precision Oncology in Lung Cancer
Session Chair: Sonam Puri, MD
11:15 AM to 11:35 AM Biomarker-guided therapy in metastatic lung cancer – my approach – Wallace Akerley, MD
11:35 AM to 11:55 AM Targeted therapies and immunotherapy in adjuvant treatment of lung cancer – Narjust Duma, MD
11:55 AM to 12:15 PM Case-based discussion – Sonam Puri, MD
12:15 PM to 1:15 PM LUNCH/ABSTRACTS
12:30 PM to 1:00 PM Lunch & Learn with Dr. Hatim Husain in Topaz Room
EGFR Exon 20 Insertion Mutations: Emerging Implications for the Management of Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Presented by: Janssen Oncology
*This activity is not part of the CME program.
1:15 PM to 2:30 PM Session 4: Precision Oncology in GI Malignancies
Session Chair: Chandrikha Chandrasekharan, MD
1:15 PM to 1:40 PM Targeted therapies in management of metastatic and loco-regional colorectal cancer – Sakti Charkrabarti, MD
1:40 PM to 2:05 PM Precision oncology approaches in hepatobiliary and pancreatic malignancies – Vaia Florou, MD
2:05 PM to 2:30 PM Case-based discussion – Chandrikha Chandrasekharan, MD
2:30 PM – 2:50 PM BREAK
2:50 PM to 3:40 PM Session 5: Precision oncology in prostate cancer and melanoma
Moderator: Benjamin Maughan, MD
2:50 PM to 3:15 PM Precision-guided approach to management of metastatic prostate cancer – Neeraj Agarwal, MD
3:15 PM to 3:40 PM Immunotherapy and other targeted therapies in management of melanoma – Siwen Hu-Lieskovan, MD
3:40 PM to 4:05 PM Case-based discussion – Benjamin Maughan, MD
4:05 PM to 4:30 PM Impact of precision oncology approaches on the lives of patients: the humanistic perspective – Mark Lewis, MD
4:30 PM to 4:45 PM Concluding remarks
 | Siddhartha Yadav, MDMedical Oncologist Mayo Clinic |  | Sakti Chakrabarti, MDAssociate Professor of Medicine Medical College of Wisconsin |
 | Benjamin Maughan, MD, PharmDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |  | Vivek Subbiah, MDAssociate Professor of Medicine MD Anderson Cancer Center, University of Texas |
 | Narjust Duma, MDAssistant Professor of Medicine Dana-Farber Cancer Institute/Harvard University |  | Mark Lewis, MDMedical Oncologist Intermountain Healthcare |
 | Christos Vaklavas, MDAssociate Professor of Medicine Huntsman Cancer Institute, University of Utah |  | Vaia Florou, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |
 | Wallace Akerley, MDProfessor of Medicine Huntsman Cancer Institute, University of Utah |  | Neeraj Agarwal, MDProfessor of Medicine Huntsman Cancer Institute, University of Utah |
 | Sonam Puri, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |  | Siwen Hu-Lieskovan, MD, Ph.D.Associate Professor of Medicine Huntsman Cancer Institute, University of Utah |
 | Stephanie Graff, MDMedical Oncologist Brown University |  | Chandrika Chandrasekharan, MDClinical Assistant Professor University of Iowa |
| Manish Kohli, MDProfessor of Medicine Huntsman Cancer Institute, University of Utah |
| Mark Pegram, MDProfessor of Medicine Stanford University |
 | Jack West, MDProfessor of Medicine City of Hope | ||
The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
The Binaytara Foundation designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 6.5 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.5 Contact Hours.
ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Available Credit
- 6.50 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 6.50 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 6.50 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.50 Contact Hours.
PLEASE VISIT OUR EXHIBITORS IN THE EXHIBIT HALL
We have exhibit and Industry Sponsored Symposia opportunities available at both of these meetings - The 2021 Updates on Hematologic Malignancies & this Precision Oncology Summit.
Register to exhibit at this conference here - Salt Lake City Conference Exhibit Registration
If you would like to register to attend only, please proceed to registration and select "industry representative' for your registration type. All participants who are employed by an ACCME defined ineligible entity must register as industry representative even if they are licensed healthcare professionals.
Price
COVID-19 Precautions
COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in.
Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.
Registration Fees
Physicians (MD/DO) - $200
Non-Physician (RN/NP/PA/PharmD) - $125
Residents/Fellows - Free registration - see instructions below*
*If you are a resident or fellow in the United States, please create a user account on this portal using your work email, and send us an email from the email address used to create the account with the name of the conference(s) that you are interested in attending, and we will register you for free.
*If you are a resident or fellow from outside the United States, please create a user account on this portal using your work email if available, and send us an email from the email address used to create the account with the following information, and we will register you for free.
- Name of the conference(s) that you are interested in attending
- A picture ID or another document showing proof of your status as Resident/Fellow/Physician in training
- Name and email address of program director to verify your trainee status
Non-displaying industry representative - $550
Displaying industry representative (not covered by the display fee) - $450
If you are employed by the industry, you must register as "Industry representative" even if you are a licensed healthcare provider not involved in the sales of product. The industry price is applicable to everyone who are employed by an ACCME defined ineligible company.